Bumper Offer - Urjas oil Just @ Rs. 1
Emgrast is a prescription medicine that is available as a Injection. Neutropenia are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Emgrast. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Emgrast can also lead to other problems, which have been listed below. Usually, these side effects of Emgrast go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Emgrast has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Emgrast's effects on the liver, heart and kidney are discussed below in the Emgrast related warnings section.
Emgrast can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Emgrast in conditions like Blood Cancer. Other conditions have been mentioned below in the Emgrast contraindications section.
Drug reaction of Emgrast with other medicines has been reported. See below for a complete list.
You should also be aware that Emgrast is safe while driving, and is addiction.
Emgrast is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Emgrast is used -
Moderate
Mild
Is the use of Emgrast safe for pregnant women?
Emgrast can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Emgrast right away. Take your doctor's advice before taking it again.
Is the use of Emgrast safe during breastfeeding?
Breastfeeding women may feel side effects of Emgrast. If you see any side effects, stop taking Emgrast immediately and talk to your doctor. Take Emgrast again, only after your doctor's advice.
What is the effect of Emgrast on the Kidneys?
Emgrast may have mild side effects on the kidneys.
What is the effect of Emgrast on the Liver?
Emgrast is rarely harmful for the liver.
What is the effect of Emgrast on the Heart?
Emgrast may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Emgrast should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Emgrast unless your doctor advises you to do so -
Is this Emgrast habit forming or addictive?
No, you will not get addicted to Emgrast.
Is it safe to drive or operate heavy machinery when consuming?
Emgrast does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Emgrast is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Emgrast for mental disorders.
Interaction between Food and Emgrast
There is no information on the effects of taking Emgrast with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Emgrast
Due to lack of research, there is no information about the side effects of taking Emgrast with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neupogen® (Filgrastim)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 567-560
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neupogen® (Filgrastim)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 567-560
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neupogen® (Filgrastim)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 567-560
